Search

everythinglearnresearchcommunity

for

Search:↓

Nourella® effectively improves skin thickness and elasticity, reversing aging signs.

Oral etretinate improved hair length and reduced beading in monilethrix.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Solid Lipid Particle technology makes retinol more stable, effective, and gentle on the skin.

Acitretin improved monilethrix symptoms temporarily, but they returned after stopping treatment.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

A man had a rare skin reaction from a hair loss medication, which improved after stopping the drug.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Ritlecitinib has common side effects like headache and acne, and unexpected ones like diabetes and thyroid issues.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

The document is retracted and cannot be summarized.

The new delivery system makes retinol and niacinamide more stable and effective for anti-aging and skin-brightening.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

New retinoids are effective for various skin conditions and are being developed to have fewer side effects.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.